Free Trial
NASDAQ:IOBT

IO Biotech (IOBT) Stock Price, News & Analysis

IO Biotech logo
$1.84 -0.24 (-11.54%)
Closing price 04:00 PM Eastern
Extended Trading
$1.88 +0.04 (+2.17%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About IO Biotech Stock (NASDAQ:IOBT)

Key Stats

Today's Range
$1.80
$2.05
50-Day Range
$1.05
$2.40
52-Week Range
$0.66
$2.79
Volume
1.25 million shs
Average Volume
1.24 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

IO Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

IOBT MarketRank™: 

IO Biotech scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IO Biotech has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    IO Biotech has a consensus price target of $8.00, representing about 325.5% upside from its current price of $1.88.

  • Amount of Analyst Coverage

    IO Biotech has only been the subject of 1 research reports in the past 90 days.

  • Read more about IO Biotech's stock forecast and price target.
  • Earnings Growth

    Earnings for IO Biotech are expected to grow in the coming year, from ($1.35) to ($1.32) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IO Biotech is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IO Biotech is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IO Biotech has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about IO Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    2.50% of the float of IO Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    IO Biotech has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IO Biotech has recently decreased by 16.89%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    IO Biotech does not currently pay a dividend.

  • Dividend Growth

    IO Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.50% of the float of IO Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    IO Biotech has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IO Biotech has recently decreased by 16.89%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    IO Biotech has a news sentiment score of 1.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for IO Biotech this week, compared to 2 articles on an average week.
  • Search Interest

    Only 22 people have searched for IOBT on MarketBeat in the last 30 days. This is a decrease of -12% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added IO Biotech to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IO Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.30% of the stock of IO Biotech is held by insiders.

  • Percentage Held by Institutions

    54.76% of the stock of IO Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about IO Biotech's insider trading history.
Receive IOBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IOBT Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
IO Biotech's Phase 3 Trial Fails To Deliver
See More Headlines

IOBT Stock Analysis - Frequently Asked Questions

IO Biotech's stock was trading at $0.92 at the beginning of 2025. Since then, IOBT shares have increased by 104.3% and is now trading at $1.88.

IO Biotech, Inc. (NASDAQ:IOBT) released its quarterly earnings results on Thursday, August, 14th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.35) by $0.05.

IO Biotech (IOBT) raised $111 million in an initial public offering on Friday, November 5th 2021. The company issued 7,150,000 shares at a price of $14.00-$17.00 per share.

Top institutional investors of IO Biotech include Bank of America Corp DE, Marex Group plc, XTX Topco Ltd and NewEdge Advisors LLC (0.04%). Insiders that own company stock include Holdings A/S Novo, Vivo Capital Ix, Llc, Amy Sullivan, Mai-Britt Zocca, Heidi Hunter and Brian Burkavage.
View institutional ownership trends
.

Shares of IOBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IO Biotech investors own include COMPASS Pathways (CMPS), Nkarta (NKTX), PayPal (PYPL), AbCellera Biologics (ABCL), atai Life Sciences (ATAI), Meta Platforms (META) and

Company Calendar

Last Earnings
8/14/2025
Today
9/15/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IOBT
CIK
1865494
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$4.00
Potential Upside/Downside
+284.6%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$95.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-281.82%
Return on Assets
-169.29%

Debt

Debt-to-Equity Ratio
4.22
Current Ratio
1.96
Quick Ratio
1.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.71 per share
Price / Book
2.93

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.41

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:IOBT) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners